UBS Group’s ETRACS 2x Leveraged US Size Factor TR ETN IWML Stock Holding History

UBS Group’s Portfolio IWML Stock Details IWML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$227K	Buy	9,795 +9,773	+44,423%	+$248K	﹤0.01%	6563
2025 Q4	$516	Buy	+22	New	+$514	﹤0.01%	9919
2025 Q3	–	Sell	-182	Closed	-$3.38K	–	10606
2025 Q2	$3.38K	Buy	182 +145	+392%	+$2.38K	﹤0.01%	9361
2025 Q1	$631	Buy	+37	New	+$758	﹤0.01%	9705
2024 Q4	–	Sell	-2,188	Closed	-$47.3K	–	10170
2024 Q3	$47.3K	Buy	2,188 +2,135	+4,028%	+$43.5K	﹤0.01%	6850
2024 Q2	$980	Buy	+53	New	+$977	﹤0.01%	8710
2024 Q1	–	Sell	-2,990	Closed	-$55.3K	–	9681
2023 Q4	$55.3K	Buy	+2,990	New	+$44.7K	﹤0.01%	6480
2022 Q3	–	Sell	-29	Closed	–	–	10623
2022 Q2	$0	Buy	+29	New	+$505	﹤0.01%	10620

Other funds holding IWML

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

UBS Group's IWML Position: Q1 2026 in Review

UBS Group increased its ETRACS 2x Leveraged US Size Factor TR ETN (IWML) stake by 44,423% in Q1 2026, buying an estimated $248K and bringing the position to 9,795 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #6563.

UBS Group first reported a position in IWML in Q2 2022 and has held it in 8 quarters since. 2 funds tracked by Wall St. Rank hold IWML as of Q1 2026.

UBS Group held 9,795 shares of ETRACS 2x Leveraged US Size Factor TR ETN worth $227K as of Q1 2026.
UBS Group bought 9,773 ETRACS 2x Leveraged US Size Factor TR ETN shares in Q1 2026, an estimated $248K.
ETRACS 2x Leveraged US Size Factor TR ETN made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6563 holding.
UBS Group first reported a position in ETRACS 2x Leveraged US Size Factor TR ETN in Q2 2022 and has held it in 8 quarters since.
2 funds tracked by Wall St. Rank held ETRACS 2x Leveraged US Size Factor TR ETN as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.